Results 151 to 160 of about 29,657 (272)

Risk factors for infection after carbapenem-resistant Acinetobacter baumannii colonization

open access: yesEuropean Journal of Clinical Microbiology & Infectious Diseases
Abstract Purpose Predicting infection risk in carbapenem-resistant Acinetobacter baumannii (CRAB) colonized patients may help in improving timely appropriate antibiotic therapy. This study aims to explore risk factors for developing infections in hospitalized patients with previous CRAB colonization.
Peghin, Maddalena   +6 more
openaire   +2 more sources

Prevalence of ESBL-producing Escherichia coli from different canine populations in Italy [PDF]

open access: yes, 2016
DOTTO, GIORGIA   +5 more
core   +1 more source

Joint surveillance and correlation analysis of antimicrobial resistance and consumption of seven targeted bacteria, 2017–2023

open access: yesScientific Reports
Antimicrobial resistance has been a major global threat to public health with the emergence of multidrug-resistant bacteria. We investigated the temporal trends in antimicrobial resistance and explored the relationships between antimicrobial consumption ...
Qiao Yuan   +3 more
doaj   +1 more source

Prevalence and antimicrobial-resistance characterization of vancomycin resistant enterococci (VRE) strains in healthy household dogs in Italy [PDF]

open access: yes, 2016
DOTTO, GIORGIA   +4 more
core   +1 more source

CHROMagar Acinetobacter medium for detection of carbapenemase-producing Acinetobacter spp. strains from spiked stools [PDF]

open access: yes, 2016
The recently modified CHROMagar Acinetobacter medium was evaluated for detection of carbapenemase-producing Acinetobacter baumannii from spiked stools. A total of 45 Acinetobacter spp. isolates were tested.
Girlich, Delphine, Nordmann, Patrice
core  

Detection of Carbapenemases Emerging in Acinetobacter baumannii Clinical Isolates by Modified Hodge Test

open access: yesJournal of Medical Microbiology and Infectious Diseases, 2014
Introduction: Acinetobacter baumannii, a known causative agent of nosocomial infections, is one of the highly antibiotic-resistant gram-negative bacilli. Carbapenem-resistant Acinetobacter isolates are increasingly reported worldwide. Carbapenems such as
Mojtaba Moosavian   +2 more
doaj  

Carbapenem-resistant Acinetobacter baumannii contamination in an intensive care unit

open access: gold, 2022
Otávio Hallal Ferreira Raro   +3 more
openalex   +1 more source

Efficacy of the small molecule inhibitor of Lipid II BAS00127538 against Acinetobacter baumannii

open access: yesDrug Design, Development and Therapy, 2014
Erik PH de Leeuw Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA Objective: To test the activity of a small molecule compound that targets Lipid II against Acinetobacter baumannii.
de Leeuw EPH
doaj  

Home - About - Disclaimer - Privacy